Apogee Therapeutics, Inc.（APGE）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 Apogee Therapeutics, Inc.（APGE）报告了 137 笔 Form 4 交易（最近一笔 2026-09-03）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-03 | JONES WILLIAM A JR | 董事 | 卖出 | 34,824 | $0 |
| 2026-09-03 | Kiselak Tomas | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Harwin Peter Evan | 董事 | 卖出 | 340,855 | $0 |
| 2026-09-03 | Shah Nimish P | 董事 | 卖出 | 1.8M | $236.4M |
| 2026-09-03 | McKenna Mark C. | 董事 | 卖出 | 20,000 | $0 |
| 2026-09-03 | Fairmount Healthcare Fund II L.P. | 董事 | 卖出 | 340,855 | $0 |
| 2026-09-03 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | 卖出 | 920,941 | $0 |
| 2026-09-03 | Henderson Jane | Chief Financial Officer | 卖出 | 158,371 | $0 |
| 2026-09-03 | Kiselak Tomas | 董事 | 卖出 | 340,855 | $0 |
| 2026-09-03 | Fox Jennifer A. | 董事 | 卖出 | 34,824 | $0 |
| 2026-09-03 | Dambkowski Carl | Chief Medical Officer | 卖出 | 1,375 | $185,708 |
| 2026-09-03 | Harwin Peter Evan | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Fairmount Healthcare Fund II L.P. | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Fairmount Funds Management LLC | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Kiselak Tomas | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Dambkowski Carl | Chief Medical Officer | 卖出 | 167,123 | $0 |
| 2026-09-03 | Harwin Peter Evan | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Fairmount Healthcare Fund II L.P. | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Fairmount Funds Management LLC | 董事 | 卖出 | 51,166 | $0 |
| 2026-09-03 | Fairmount Funds Management LLC | 董事 | 卖出 | 340,855 | $0 |
| 2026-08-11 | Harwin Peter Evan | 董事 | 买入 | 31,838 | $541,246 |
| 2026-08-11 | Fairmount Healthcare Fund II L.P. | 董事 | 买入 | 31,838 | $541,246 |
| 2026-08-11 | Fairmount Funds Management LLC | 董事 | 买入 | 31,838 | $541,246 |
| 2026-08-11 | Kiselak Tomas | 董事 | 买入 | 31,838 | $541,246 |
| 2026-08-11 | Harwin Peter Evan | 董事 | 买入 | 10,370 | $454,724 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03